Lupus drug safety in pregnancy under scrutiny: new study launches
NCT ID NCT06795893
First seen Dec 12, 2025 · Last updated Apr 29, 2026 · Updated 15 times
Summary
This study tracks 240 pregnant women with lupus who have taken the medication anifrolumab. Researchers want to see if the drug increases the risk of birth defects or other pregnancy problems. The goal is to gather safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Reseach Facility
RECRUITINGSödertälje, Sweden
Conditions
Explore the condition pages connected to this study.